Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions
about
Systems biology of the microvasculatureExtracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.A systems biology view of blood vessel growth and remodellingGlycolytic regulation of cell rearrangement in angiogenesis.β3 Integrin Promotes Long-Lasting Activation and Polarization of Vascular Endothelial Growth Factor Receptor 2 by Immobilized Ligand.Paclitaxel targets VEGF-mediated angiogenesis in ovarian cancer treatmentQuantitative characterization of cellular membrane-receptor heterogeneity through statistical and computational modelingA multiscale computational model predicts distribution of anti-angiogenic isoform VEGF165b in peripheral arterial disease in human and mousePharmacokinetics of Anti-VEGF Agent Aflibercept in Cancer Predicted by Data-Driven, Molecular-Detailed Model.Predictive model of thrombospondin-1 and vascular endothelial growth factor in breast tumor tissueAntiangiogenic cancer drug sunitinib exhibits unexpected proangiogenic effects on endothelial cells.Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities.Computational systems biology approaches to anti-angiogenic cancer therapeutics.Quantification of the concentration gradient of biomarkers between ovarian carcinoma interstitial fluid and blood.A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands.Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice.Cancer prevention and therapy through the modulation of the tumor microenvironment.Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis.Stromal-epithelial crosstalk provides a suitable microenvironment for the progression of ovarian cancer cells in vitro.Systems Approaches to Cancer BiologyThe Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts.Quantitative fluorescent profiling of VEGFRs reveals tumor cell and endothelial cell heterogeneity in breast cancer xenografts.Blood-based biomarkers for monitoring antiangiogenic therapy in non-small cell lung cancer.A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer.Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer.Multi-scale Modeling in Clinical Oncology: Opportunities and Barriers to Success.Monitoring Severity of Multiple Organ Dysfunction Syndrome: New Technologies.Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration.Quantitative insight in utilizing circulating angiogenic factors as biomarkers for antiangiogenic therapy: systems pharmacology approach.Can we identify predictive biomarkers for antiangiogenic therapy of cancer using mathematical modeling?Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment.Quantum dot multiplexing for the profiling of cellular receptors.VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma.
P2860
Q26850123-0BCF0C83-038A-4C46-9198-8397E9F9ED50Q27000351-EF34F096-43DE-4BB4-83B3-1FE48A89FF34Q27003945-D7AE401C-513C-432F-807B-A8F66A67D677Q27335102-6FFCC8E7-9D19-4B2C-BC59-7043AD61F444Q27342136-81869ED1-20E7-4DCC-875F-D47D198C7455Q28073057-8CD8D350-9E34-4D2F-81D7-0C2EDC7B8A8DQ28538791-086C0048-AD4F-4C96-98B1-609C49E57D69Q30275400-8290A2C0-FB59-4084-A5CF-306ABF6248DFQ31037873-F8052614-BC09-44F1-A070-89BB35D0EAF1Q33897971-DBDCDACD-4CF4-4D82-8C3E-FCE1047BDB74Q34182311-97D07CE1-2D52-4CDA-A815-DE8FAC0CBD3AQ35104052-25D404E0-6644-41A9-BF1B-25932DC1EC0BQ35108084-CC79ACDC-55BD-4EFF-8BD8-13F97FBA2F21Q36250701-47732972-92DB-469C-A12F-9A11183DAFB6Q36314931-7797C718-C0AF-4608-9EFE-0C465ADB50DDQ37054876-FE1D396F-5131-40AF-813C-3420265063E8Q37058267-DE5805CE-6AF5-4A67-AF48-C13E0091DEC7Q37411899-37A70997-43BF-4822-BEEA-61386B791FBDQ37460975-1F70CD45-A6AD-4DD8-9C60-E1EA36E953A0Q37470084-B110DAC7-F419-495A-B9E0-A4770EFD2645Q37519061-7BFC0BDB-EFB5-4734-80A8-DCC330B78847Q37703365-F1B622FC-B2FF-42DE-BF12-DD7287CCAF9CQ38443447-4EF716F4-566F-47E3-9753-CF8B8D55C6CFQ38749030-7B799863-F01E-4514-A15F-2AA6FDDAC45BQ38757677-2F3C7C70-2164-4547-BBCE-87E9EB6655E5Q38888255-8FA7F41A-4EB8-42D5-A0F4-761613D939A3Q38935727-670307C6-36FF-4874-9B4A-44DD5C172603Q39014534-F8D34424-D590-48D5-9777-629D870ABBC1Q42418396-4E105906-AD49-4D03-BDC5-70B279D82E3EQ43141618-1CDFF9E5-2276-4B87-9240-853A4D372FD2Q47228068-3587E83D-BA5B-4A91-A5F4-87021FB2626FQ51717661-C6123CDF-2417-45E9-97ED-A36E74659782Q55064617-B0510C0A-277E-4403-B0AA-AEC90E3D2D39
P2860
Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effect of tumor microenvironme ...... t: systems biology predictions
@en
type
label
Effect of tumor microenvironme ...... t: systems biology predictions
@en
prefLabel
Effect of tumor microenvironme ...... t: systems biology predictions
@en
P2860
P356
P1476
Effect of tumor microenvironme ...... t: systems biology predictions
@en
P2093
Aleksander S Popel
Stacey D Finley
P2860
P304
P356
10.1093/JNCI/DJT093
P407
P577
2013-05-13T00:00:00Z